Document is current

Any future updates will be listed below

Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

Crossref DOI link: https://doi.org/10.1186/s12885-016-2645-y

Published Online: 2016-08-08

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark